Abstract

Pyruvate dehydrogenase deficiency is a rare mitochondrial disease characterized by a wide range of neurometabolic manifestations. The disease is caused by insuffici ency of this multienzyme complex, which ensures the integration of pyruvate (the carbohydrate metabolism product) into the cellular energy metabolism. This complex deficiency is mostly caused by the mutations in the E1 alpha subunit-encoding PDHA1 (Xp22.1) gene. The article presents a clinical case of a boy with pyruvate dehydrogenase deficiency. The patient was diagnosed on the basis of a combination of clinical, laboratory and instrumental data: retardation in physical and psychomotor development, diffuse muscle hypotension, lactic acidosis, neurological manifestations, thalamus signal changes (according to magnetic resonance imaging of the brain), hemizygous mutations of the 12th exon of the PDHA1 gene during exomic DNA sequencing. We observed positive dynamics against metabolic therapy. The authors emphasize the importance of the timely diagnostics and initiation of metabolic therapy. Late diagnostics causes irreversible complications and significantly worsens the quality of patient’s life

Highlights

  • Pyruvate dehydrogenase deficiency is a rare mitochondrial disease characterized by a wide range of neurometabolic manifestations

  • The disease is caused by insufficiency of this multienzyme complex, which ensures the integration of pyruvate into the cellular energy metabolism

  • This complex deficiency is mostly caused by the mutations in the E1 alpha subunit-encoding PDHA1 (Xp22.1) gene

Read more

Summary

Introduction

Pyruvate dehydrogenase deficiency is a rare mitochondrial disease characterized by a wide range of neurometabolic manifestations. Дефицит пируватдегидрогеназного комплекса – редкое митохондриальное заболевание у 4-летнего мальчика. Дефицит пируватдегидрогеназного комплекса (МКБ-10: E74.4, OMIM: No245348, No245349, No246900, No312170, No608782, 614111) – редкое нейрометаболическое митохондриальное заболевание, характеризующееся широким спектром клинических признаков с неврологическими и метаболическими проявлениями различной степени тяжести. При недостаточности пируватдегидрогеназного комплекса клиническая картина болезни значительно варьирует по степени тяжести и возрасту дебюта.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call